- Healthy Extracts Inc. through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”) is focused on building a stronghold in the nutraceuticals market
- BergaMet NA is the only company authorized to manufacture, distribute, and sell Citrus Bergamot SuperFruit(TM) in North America, a supplement enriched with the world’s best quality polyphenols and flavonoids
- BergaMet North America’s HERHEART(TM) is a natural supplement, scientifically formulated to support woman’s cardiovascular health, as well as managing perimenopausal symptoms
Healthy Extracts (OCTQB: HYEX) through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”) is focused on the proprietary research, development, and sale of natural plant-based formulations offering supplements, beneficial for cardiovascular and neuro health. These two-million-dollar industries catering to the high-margin and high-growth categories reflect the company’s commitment to strengthening its position in the multibillion-dollar nutraceuticals market.
Acquired by Healthy Extracts in 2019, BergaMet NA is engaged in the sale and distribution of a full line of proprietary product formulations derived from the rare Citrus Bergamot SuperFruit(TM) called “Bergamot”, the only heart health supplement backed by 17 clinical studies. The Bergamot supplement is enriched with the world’s best quality polyphenols and flavonoids, proving a boon to thousands of people who suffer from cardiovascular diseases. BergaMet NA is the only company authorized to manufacture, distribute, and sell these products in the United States, Canada, and Mexico.
Enriched with antioxidant polyphenols, BergaMet is a Mediterranean fruit whose immense health properties have been supported by Dr. Joel Kahn, M.D., an eminent, triple board-certified cardiology specialist, who recently joined the company’s medical board. Dr. Kahn advocates the benefits of using BergametNA Citrus Bergamot SuperFruit for heart health namely positive arterial age reversal and arterial flexibility. He has tested the formulation on several patients and approved the product’s cardiovascular health benefits along with no known side effects (https://ibn.fm/ciDXF).
Research and clinical studies show positive results for two leading products of the company, BergaMet North America’s HERHEART(TM) and Ultimate Brain Nutrients’ Fuel4Thought(TM) Brain Booster. Clinical studies show positive results in brain activation, sports vision, cognitive function, clarity, energy, and ketone benefits (https://ibn.fm/mhX7W).
HERHEART(TM) is a natural supplement, being touted to become the company’s top-selling products, under the leadership of the world-renowned health expert Dr. Nesochi Okeke-Igbokwe MD., M.S, who recently joined the company’s Medical Advisory Board. The formulation is scientifically formulated to support a woman’s cardiovascular health, as well as managing perimenopausal symptoms (https://ibn.fm/M10yz).
For more information, visit the company’s website at www.HealthyExtractsInc.com.
NOTE TO INVESTORS: The latest news and updates relating to HYEX are available in the company’s newsroom at https://ibn.fm/HYEX
About Healthy Extracts Inc.
“Live Life Young Again”
Healthy Extracts Inc. (OCTQB: HYEX) serves as a platform for developing and acquiring complementary companies that feature science-forward, clinically proven, plant-based and proprietary products in select high-margin and high-growth categories within the multibillion-dollar nutraceuticals market – the first two multimillion-dollar examples of which have already been launched.
Company subsidiaries BergametNA(TM) and Ultimate Brain Nutrients(TM) (“UBN”) are providers of nutraceutical natural heart and brain health supplements, including the only heart health supplement containing Citrus Bergamot SuperFruit(TM), the highest quality and concentration of polyphenols and flavonoids available anywhere in the world and exclusive to BergametNA in North America and backed by 17 clinical studies. UBN’s KETONOMICS(R) proprietary formulations improve brain health, including memory, cognition, focus and neuro-energy, and have multiple intellectual property license opportunities for monetizing the company’s portfolio. UBN has six unique formulation patents – two issued and four pending.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as “projected,” “expect,” “possibility” and “anticipate.” The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2020, and future periodic reports filed with the SEC. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
InvestorWire is part of the InvestorBrandNetwork.